SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-324578
Filing Date
2020-12-22
Accepted
2020-12-22 16:34:12
Documents
14
Period of Report
2020-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d80460d8k.htm   iXBRL 8-K 30783
2 EX-99.1 d80460dex991.htm EX-99.1 13048
6 GRAPHIC g80460g1222121221951.jpg GRAPHIC 2986
  Complete submission text file 0001193125-20-324578.txt   177468

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20201222.xsd EX-101.SCH 3061
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20201222_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20201222_pre.xml EX-101.PRE 11402
7 EXTRACTED XBRL INSTANCE DOCUMENT d80460d8k_htm.xml XML 3349
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 201408323
SIC: 2836 Biological Products, (No Diagnostic Substances)